Floatz logo

Azacitidine

FLT3 Internal Tandem Duplication Positive

First Affiliated Hospital of Zhejiang UniversitySmall moleculePhase 2Active
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the FLT3 Internal Tandem Duplication Positive cohort.

Asset / SponsorPhaseRating
Gemtuzumab Ozogamicin
First Affiliated Hospital of Zhejiang University
Phase 2CCC

Same molecule, other indications

Azacitidine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
73 / 100
View asset →
acute erythroid leukemiaDormant
BB
Indicative ·
71 / 100
View asset →
non-small cell lung carcinomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →